Breast cancer pill shows benefit in certain hard-to-treat cases
Fox News
A pill has been shown to help keep certain early-stage, hard-to-treat breast cancers at bay after initial treatment in findings being reported early because they are so promising.
The pill, called Lynparza, was found to help breast cancer patients with harmful mutations live longer without disease after their cancers had been treated with standard surgery and chemotherapy. It was studied in patients with mutations in genes known as BRCA1 and BRCA2 that can predispose people to breast cancer if they don't work properly, but who did not have a gene flaw that can be targeted by the drug Herceptin.More Related News